Loading clinical trials...
Loading clinical trials...
A Registry-Based Observational Study Assessing Clinical Outcomes In Familial Adenomatous Polyposis In Patients Receiving Celecoxib (Celebrex(Registered), Onsenal(Registered)) Compared With Control Patients
Conditions
Interventions
Celecoxib
Routine Medical Care
Locations
4
United States
Pfizer Investigational Site
Cleveland, Ohio, United States
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Hvidovre, Copenhagen, Denmark
Pfizer Investigational Site
Barcelona, Spain
Start Date
November 1, 2004
Primary Completion Date
November 1, 2008
Completion Date
November 1, 2008
Last Updated
September 4, 2024
NCT06950385
NCT07461246
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions